A Safety Study of LY3437943 Given as a Single Injection in Healthy Participants

Phase 1 study, condition: Healthy. This study is being conducted to determine the side effects related to LY3437943 given as a single injection under the skin to healthy participants. Blood tests will be performed to check how much LY3437943 gets into the bloodstream and how long the body takes to get rid of it. Each enrolled participant will receive a single dose of LY3437943 or placebo. The study will last up to approximately 71 days for each participant, including screening. Enrolment: 45 participants. Status: completed. No topline or peer-reviewed results are verified for publication on this Record for this study — registry facts only.